NICE acts to speed lung cancer diagnosis and treatment
March 2, 2005Patients showing symptoms of lung cancer should be offered an urgent referral to a chest physician, according to NICE recommendations …
Singulair gains dual asthma-hayfever indication
March 2, 2005Sales and Marketing
Merck Sharpe & Dohme's blockbuster oral asthma treatment Singulair has received an expanded UK licence for the treatment of adult …
NHS is behind us, says rep-free Takeda
March 1, 2005Sales and Marketing Davis, Takeda, sales and marketing
Takeda UK says new market research shows healthcare professionals and NHS managers are in favour of its revolutionary move away …
Cymbalta approved for second indication
February 24, 2005Sales and Marketing
Cymbalta has received European approval for diabetic peripheral neuropathic pain (DPNP) in adults, with its marketers keen to meet what …
Reassessing medical communications
February 24, 2005It's time to be less defensive about perfectly legitimate medical communications methods providing contentious 'sharp practices' can be consigned to …
Sankyo and Daiichi set to continue Japanese consolidation
February 24, 2005Sales and Marketing
Two of Japan's leading pharmaceutical companies Sankyo and Daiichi look set to merge later this year, accelerating consolidation in the …
FDA panel clears Vioxx return to market
February 21, 2005Sales and Marketing
An FDA panel has narrowly voted in favour of allowing Vioxx to return to the market, after concluding it carries …
IMS and Innovex announce UK alliance
February 17, 2005Sales and Marketing
Pharma data consultants IMS have announced a new alliance with contract sales provider Innovex to supply its field forces with …
ADHD latest drugs to be hit by safety warnings
February 17, 2005Sales and Marketing
Attention deficit hyperactivity disorder (ADHD) treatments are the latest class of drugs to be hit by safety warnings, with regulators …
New FDA drug safety board to be more independent
February 17, 2005Sales and Marketing
A new independent FDA board will be set up to monitor drug safety and issue warnings to doctors and patients …
New customers: new education
February 16, 2005Doctors have for a long time been the primary influencers of prescribing and chronic disease management. For pharma companies, that …
NHS to be key election issue as Blair unveils pledge
February 15, 2005Blair, NHS
Tony Blair has signalled Labour’s record on the NHS will be one of the key issues on which it will …
Chronic disease programme needs more work, says think tank
February 14, 2005The new system of chronic disease management currently being piloted in ten PCTs needs further evaluation before it is extended …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
